Assenagon Asset Management S.A. Sells 214,706 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Assenagon Asset Management S.A. lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 92.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 16,977 shares of the company's stock after selling 214,706 shares during the quarter. Assenagon Asset Management S.A.'s holdings in Henry Schein were worth $1,163,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV bought a new position in Henry Schein during the fourth quarter valued at approximately $32,000. Venturi Wealth Management LLC grew its holdings in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares during the last quarter. Allworth Financial LP grew its holdings in Henry Schein by 180.7% during the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock valued at $71,000 after purchasing an additional 609 shares during the last quarter. Finally, UMB Bank n.a. grew its holdings in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Barrington Research lowered their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a report on Tuesday, May 6th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Wells Fargo & Company lowered their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Finally, UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Stock Performance

Shares of HSIC traded up $0.97 during mid-day trading on Thursday, hitting $71.13. The company's stock had a trading volume of 2,312,262 shares, compared to its average volume of 1,697,204. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. The firm has a market capitalization of $8.66 billion, a PE ratio of 22.23, a price-to-earnings-growth ratio of 2.29 and a beta of 0.86. The stock's 50-day moving average is $68.79 and its two-hundred day moving average is $71.30.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. Henry Schein's revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.10 earnings per share. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.